Product
QLF32004
1 clinical trial
1 indication
Indication
Advanced TumorClinical trial
Phase Ia Clinical Study of Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of QLF32004 for Injection Monotherapy in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2024-12-30